MedTrace Logo

Exercise for Patients With Heart Failure in Primary Care: the EFICAR

NCT01033591 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2014-12-23

No results posted yet for this study

Summary

Quality of life decreases as the heart failure worsens and is one of the biggest worries of these patients. Physical exercise has been shown as a safe intervention for people with heart failure. Previous studies have tested heterogeneous exercise programs using different QoL instruments and reported that the effects on QoL are inconsistent. The aim of this study is to evaluate the effectiveness of a new exercise program for people with heart failure (EFICAR), additional to the recommended optimal treatment in primary care, to improve QoL, functional capacity and cardiovascular risk factor control.

Conditions

Interventions

BEHAVIORAL

Supervised progressive exercise program with an aerobic and a strength component + Optimized treatment

Three month supervised progressive exercise program with an aerobic (high intensity intervals) and a strength component; and the programme will continue linked with community resources for 9 months

BEHAVIORAL

Optimized treatment according to the European Society of Cardiology guidelines

Optimized treatment according to the European Society of Cardiology guidelines

Sponsors & Collaborators

  • Carlos III Health Institute

    collaborator OTHER_GOV

  • Preventive Services and Health Promotion Research Network

    collaborator OTHER

  • Castilla-La Mancha Health Service

    collaborator OTHER

  • Castilla-León Health Service

    collaborator OTHER

  • Public Health Service of Cataluña

    collaborator OTHER

  • Islas Baleares Health Service.

    collaborator UNKNOWN

  • Basque Health Service

    lead OTHER_GOV

Principal Investigators

  • Jesus Torcal, Dr. · Basauri Health Center. Basque Health Service

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01033591 on ClinicalTrials.gov